World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
115
Citations
54974
World Ranking
189
National Ranking
85

Medicine

D-Index
121
Citations
59188
World Ranking
3586
National Ranking
1979

Clifton E. Barry publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Clifton E. Barry sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 292 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Clifton E. Barry D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Clifton E. Barry sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 115 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Clifton E. Barry is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research mainly focuses on infectious diseases, with a prominent emphasis on tuberculosis and related microbiological and immunological studies. The primary fields of study include medicine and biochemistry, genetics, and molecular biology.

The subfields of Clifton E. Barry's work span infectious diseases, molecular biology, epidemiology, immunology, and surgery. Their research covers several key topics such as tuberculosis research and epidemiology, Mycobacterium research and diagnosis, diagnosis and treatment of tuberculosis, biochemical and molecular research, immune cell function and interaction, cancer therapeutics and mechanisms, and infectious diseases and tuberculosis.

Recent notable publications by Clifton E. Barry include:

  • PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis, 2020, Science
  • MAIT cell-directed therapy of Mycobacterium tuberculosis infection, 2020, Mucosal Immunology
  • Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice, 2021, The Journal of Experimental Medicine
  • Current and future treatments for tuberculosis, 2020, BMJ
  • The Tuberculosis Drug Accelerator at year 10: what have we learned?, 2021, Nature Medicine

Frequent coauthors in Clifton E. Barry's publications include Helena I. Boshoff, Laura E. Via, Sangmi Oh, Véronique Dartois, and Danielle M. Weiner. The collaborations reflect a consistent network within tuberculosis and infectious disease research communities.

Publishing venues where Clifton E. Barry's work is commonly found include bioRxiv (Cold Spring Harbor Laboratory), ACS Infectious Diseases, Nature Medicine, Mucosal Immunology, and The Journal of Experimental Medicine. These venues highlight the scientist's engagement with both pre-publication repositories and peer-reviewed journals focused on immunology and infectious diseases.

Best Publications

  • Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

    S. T. Cole;R. Brosch;J. Parkhill;T. Garnier

  • The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

    Clifton E. Barry;Helena I. Boshoff;Véronique Dartois;Thomas Dick

  • A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.

    C. Kendall Stover;Paul Warrener;Donald R. VanDevanter;David R. Sherman

  • A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

    Michael B. Reed;Pilar Domenech;Claudia Manca;Hua Su

  • Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

    Katrin D. Mayer-Barber;Bruno B. Andrade;Sandra D. Oland;Eduardo P. Amaral;Eduardo P. Amaral

  • PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release

    Ramandeep Singh;Ujjini Manjunatha;Ujjini Manjunatha;Helena I. M. Boshoff;Young Hwan Ha

  • Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

    Claudia Manca;Liana Tsenova;Amy Bergtold;Sherry Freeman

  • The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.

    Helena I.M. Boshoff;Timothy G. Myers;Brent R. Copp;Michael R. McNeil

  • Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates.

    Laura E. Via;P. Ling Lin;Sonja M. Ray;Jose Carrillo

  • Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis

    Myungsun Lee;Jongseok Lee;Matthew W. Carroll;Hongjo Choi

  • Tuberculosis: What We Don’t Know Can, and Does, Hurt Us

    David G. Russell;Clifton E. Barry;JoAnne L. Flynn

  • Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.

    Wanliang Shi;Xuelian Zhang;Xin Jiang;Haiming Yuan

  • The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages

    James J. De Voss;Kerry Rutter;Benjamin G. Schroeder;Hua Su

  • Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid

    Khisimuzi Mdluli;Khisimuzi Mdluli;Richard A. Slayden;Richard A. Slayden;Ya Qi Zhu;Ya Qi Zhu;Srinivas Ramaswamy

  • Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

    Seok Yong Eum;Ji Hye Kong;Min Sun Hong;Ye Jin Lee

  • Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

    Jean Emmanuel Hugonnet;Lee W. Tremblay;Helena I. Boshoff;Clifton E. Barry

  • Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system.

    Dirk Wagner;Jörg Maser;Barry Lai;Zhonghou Cai

  • Tuberculosis — metabolism and respiration in the absence of growth

    Helena I. M. Boshoff;Clifton E. Barry

  • Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

    David R. Sherman;Khisimuzi Mdluli;Mark J. Hickey;Taraq M. Arain

  • SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

    Kapil Tahlan;Regina Wilson;David B. Kastrinsky;Kriti Arora

Frequent Co-Authors

Helena I. Boshoff
Helena I. Boshoff National Institutes of Health
Laura E. Via
Laura E. Via National Institutes of Health
Sang-Nae Cho
Sang-Nae Cho Yonsei University
Véronique Dartois
Véronique Dartois Rutgers, The State University of New Jersey
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Gerhard Walzl
Gerhard Walzl Stellenbosch University
JoAnne L. Flynn
JoAnne L. Flynn University of Pittsburgh
Gilla Kaplan
Gilla Kaplan Bill & Melinda Gates Foundation
Dirk Schnappinger
Dirk Schnappinger Cornell University
Douglas B. Young
Douglas B. Young Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities beyond the lab. Healthcare administration and medical coding are growing fields that complement scientific knowledge with organizational and technical skills.

One popular option is becoming a Certified Professional Coder (CPC). This credential ensures expertise in medical coding and billing, critical for accurate healthcare documentation and reimbursement. To learn about this role’s requirements and benefits, consider exploring cpc programs.

Health Information Management (HIM) is another promising pathway combining healthcare and information technology. HIM specialists oversee patient data accuracy and security, contributing to effective clinical and financial operations. For insight into job prospects and earning potential, check out health information management jobs salary.

To pursue a robust HIM career, enrolling in one of the best online cahiim accredited health information management degree programs is recommended, as these ensure quality education aligned with industry standards.

If you prefer a shorter route, consider online certificate options like the fastest online medical billing and coding certificate programs for expedited entry into the field. These programs provide foundational knowledge for billing and coding roles in healthcare settings.

Best Scientists Citing Clifton E. Barry

Trending Scientists

Recently Published Articles